Please try another search
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and anus, chemotherapeutic and antineoplastic agents, respiratory system, etc., as well as vitamin preparations. It sells its generic drugs through distributors, wholesalers, and retailers in Japan and the United States. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.
Name | Age | Since | Title |
---|---|---|---|
Mitsuo Sawai | 67 | 2002 | Chairman, President, Group CEO & Group COO |
Toru Terashima | 65 | 2021 | Senior Managing Executive Officer, Group Chief Quality & Safety Officer and Director |
Shoji Yokota | 67 | 2023 | Senior Managing Executive Officer, Group Chief Research & Development Officer and Director |
Nawomi Todo | 65 | 2021 | Independent External Director |
Tadao Tsubokura | 63 | 2021 | Full-time Audit & Supervisory Board Chairman |
Masatoshi Ohara | 73 | 2021 | Lead Independent Outside Director |
Takanobu Tomohiro | 66 | 2021 | External Audit & Supervisory Board Member |
Junichi Hirano | 78 | 2021 | External Audit & Supervisory Board Member |
Masayuki Mitsuka | 70 | 2023 | External Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review